When a molded part shows a defect, an overseas buyer does not need a generic list of machine adjustments. The buyer needs a controlled decision path: define the symptom and affected population, ask what mechanisms are plausible, require checks that can separate those mechanisms, and approve a corrective action only against agreed evidence. This checklist is intended for OEM procurement, quality, and engineering teams that must communicate across sites, time zones, and disciplines without treating a visual observation as proof of root cause. It supports containment and release decisions for defects such as incomplete fill, flash, sinks, distortion, cosmetic variation, burn marks, and ejection-related damage, while keeping the investigation specific to the part.

A visible symptom may have several contributors. Resin grade and condition, part geometry, gate and vent layout, cooling, mold wear, machine capability, process history, handling, and the measurement method can all matter. The correct response therefore depends on the approved drawing, resin specification, mold configuration, production condition, and acceptance plan. Use the questions below to create an auditable supplier conversation rather than to prescribe universal temperatures, pressures, times, or tolerances.

Buyer rule: treat the symptom, the likely cause, the confirmation check, and the corrective action as four separate records. A setting change is not a root-cause conclusion, and a visually improved sample is not by itself evidence of a stable release condition.

01

1. Start with a controlled symptom statement and immediate containment

Record what is actually observed before discussing causes. Name the defect, its precise location, cavity or tool position when known, orientation, size or extent, first observed date, lot or shift, resin lot, mold and machine identifier, and whether it appears at startup, after a changeover, intermittently, or on every cycle. Attach photographs taken at an agreed scale and lighting condition, plus a marked drawing or CAD view where the location is functional or cosmetic. For a dimensional or deformation concern, state the datum scheme, conditioning state, time after molding, fixture, instrument, and operator method. These details turn a phrase such as 'warped' or 'poor surface' into a traceable symptom statement.

Containment should be proportional to the product risk and the defined acceptance criteria. Ask the supplier which material, work-in-process, and finished lots may be affected; whether parts can be segregated by cavity, time window, or resin lot; and what temporary inspection method is proposed. The buyer should decide whether suspect product is held, sorted to an agreed rule, used under concession, or rejected. Do not allow a corrective action trial to overwrite the original nonconformance record. Retain an identified before-condition sample where practical so that the claimed improvement can be compared using the same inspection method.

Illustrative injection molding banner web for injection molding defect analysis
Illustrative visual for engineering discussion; it does not depict an InjeForm customer part, facility, or production result.

02

2. Rank likely causes by mechanism, not by a defect-name shortcut

Ask the supplier to place potential causes into families and explain why each fits or does not fit the observed pattern. Resin and material handling may be relevant to streaking, discoloration, delamination, viscosity variation, or degradation. Geometry, flow path, gate position, wall transitions, and trapped-air locations may be relevant to short fill, weld lines, sinks, voids, or burning. Mold condition and design may be relevant to venting, cooling balance, parting-surface sealing, ejection, runner restrictions, or wear. Machine and process behavior may be relevant to shot consistency, transfer behavior, clamp performance, recovery, or thermal control. Measurement and handling can also create an apparent defect, particularly where a flexible part is gauged inconsistently or inspected before reaching the agreed condition.

A practical buyer question is: 'Which two or three mechanisms best explain the location, timing, cavity pattern, and recent history, and what observation would disprove each one?' For example, flash at one local parting feature may justify a close examination of the sealing condition and alignment before blaming a global setting; a repeated short region may justify review of flow resistance, venting, material delivery, and the fill pattern. The list is a hypothesis register, not a declaration. A cause from a generic troubleshooting chart must remain provisional until part-specific evidence supports it.

03

3. Require confirmation checks that can distinguish resin, geometry, mold, machine, and measurement effects

The supplier's confirmation plan should state the question being tested, the evidence to be collected, the controlled variables, the sample size or trial logic, the inspection method, and the decision criterion. Useful evidence may include retained resin identification and drying records where relevant, tool-condition photographs, gate and vent inspection observations, cooling or temperature records, cavity-to-cavity comparison, controlled samples before and after one documented change, process trend data, and dimensional or functional results. The buyer does not need to dictate the supplier's process settings, but should ask whether one change at a time is feasible and whether the test preserves a clear comparison with the baseline condition.

Confirm that the measurement method is capable of answering the question. A bowed or soft part measured free-state with calipers may not answer a functional flatness or assembly question. Ask how the part is conditioned, located, fixtured, illuminated, and measured; whether the gauge is suitable for the tolerance and feature; and how repeatability, calibration, and measurement uncertainty will be handled. If an inspection result drives a release decision, it should be tied to the controlled drawing revision and the agreed acceptance boundary, not merely to a photograph or an unqualified visual judgement.

Illustrative process dfm tool design web for injection molding defect analysis
Illustrative visual for engineering discussion; it does not depict an InjeForm customer part, facility, or production result.

04

4. Approve corrective actions only after the mechanism and trade-offs are visible

A corrective action should map directly to the supported mechanism. Depending on the evidence, it may involve material handling controls, a defined process-window adjustment, gate or vent work, cooling review, mold repair or maintenance, a design change, or an improved inspection and handling method. Ask the supplier to describe the action, its affected documents, the owner, the implementation date, and the risks it may introduce elsewhere. A change that reduces a sink may alter dimensions or cycle time; an action aimed at flash may change fill behavior; a tool intervention may affect other cavities. The correct trade-off is part- and resin-specific, so require an updated trial plan rather than relying on a universal setting recommendation.

For tool or design actions, request a marked-up drawing, mold-change description, or before-and-after images that identify the affected location. For process actions, request the controlled condition or permitted range in the supplier's internal format, not an unsupported claim that a single number will work for every resin or machine. Ask whether the action is temporary containment, permanent correction, or a proposed engineering change. If the approved product definition, material grade, mold configuration, or inspection method changes, make the buyer's review and any required change-control approval explicit before production release.

05

5. Close the issue with acceptance criteria and production-ready supplier evidence

Define acceptance before reviewing the corrected samples. Cosmetic criteria should state the viewing condition, viewing distance where applicable, permitted location, limit or reference sample, and whether the area is functional, visible after assembly, or hidden. Dimensional and functional criteria should identify the drawing revision, datums, conditioning, gauge or fixture, sampling approach, and pass/fail rule. Where a defect can be cavity-specific or intermittent, buyer and supplier should agree whether results must be reported by cavity, sequence, lot, or time window. A sample is acceptable because it meets an agreed criterion under a stated method, not because it appears improved in isolation.

Close the corrective action request with a concise evidence package: the original symptom and containment record; the ranked cause hypotheses; confirmation results; the implemented action; before-and-after sample identification; inspection and functional results; material traceability where relevant; and the release recommendation with any remaining limitations. For ongoing production, agree the control points that will show recurrence or drift, such as cavity-specific visual checks, first-off review, dimensional trend reporting, or defined escalation triggers. This provides procurement with a decision record and gives quality and engineering a basis for auditing whether the correction held beyond a single trial.

Illustrative factory quality cmm web for injection molding defect analysis
Illustrative visual for engineering discussion; it does not depict an InjeForm customer part, facility, or production result.

Practical takeaway

Before you move
to the next review.

  • Issue a defect record that identifies the symptom, location, product consequence, affected population, drawing revision, resin lot, mold, machine, cavity where known, and inspection condition; require containment before broad process changes.
  • Ask the supplier for a ranked, part-specific list of likely resin, geometry, mold, machine, handling, and measurement causes, plus the observations that would confirm or eliminate each leading hypothesis.
  • Approve a confirmation plan that states the baseline, controlled variables, proposed evidence, sample or trial logic, measurement method, and decision criterion; avoid approving a trial described only as 'adjust settings.'
  • Review each corrective action against its supported mechanism, document and change-control impact, risk to other CTQs, owner, and whether it is temporary containment or a permanent correction.
  • Release only against agreed cosmetic, dimensional, and functional acceptance criteria with a traceable evidence package, and define the production monitoring or escalation trigger needed to detect recurrence.

FAQ

Common questions

What should a buyer ask for when a supplier reports an injection molding defect?

Ask first for a controlled symptom record and containment status: what is seen, where, when, on which lots or cavities, and how it was inspected. Then request the supplier's ranked likely causes, the confirmation checks planned, the proposed corrective action, and the acceptance evidence required for release. This keeps the discussion from jumping directly from a photograph to a process adjustment.

Can a defect be assigned to one root cause from its appearance alone?

Usually not. The same appearance can have different contributors, and several contributors can coexist. A short region, for example, may warrant examination of material delivery, flow resistance, venting, gate or runner condition, and the relevant process history. Treat visual appearance as a symptom and use controlled checks to make the cause credible.

What are suitable acceptance criteria for cosmetic molding defects?

Set criteria for the actual product use: the controlled part revision, inspection lighting and viewing condition, zones that are visible after assembly, permitted and prohibited locations, and a clear pass/fail boundary or approved reference. Cosmetic acceptance should be paired with dimensional or functional requirements when the same feature could affect fit, sealing, safety, or assembly. No single cosmetic limit is suitable for every resin, texture, color, geometry, or end-use surface.

What evidence should support release after a corrective action?

Request evidence that connects the correction to the released condition: a record of containment, cause hypotheses and confirmation results, the implemented action, identified before-and-after samples, relevant inspection or functional results, material traceability where relevant, and the agreed production monitoring plan. The measurement method, part conditioning, drawing revision, and any deviation or change-control status should be clear enough for the buyer to interpret the result.

References

Source material

  1. [1] BASF Performance Materials — Injection Molding Troubleshooter
  2. [2] RJG — How to Troubleshoot 9 Common Defects in Injection Molded Parts
  3. [3] RJG — A Guide to Dimensional Inspection of Molded Parts in Plastic Injection Molding
  4. [4] NIST — Rule Model for Selecting Dimensional Measurement Equipment in Inspection Planning

This guide is general information for early procurement and engineering discussion. It does not replace product-specific DFM, qualification, validation, regulatory assessment or legal advice.